Rainbow Childrens Medicare Limited Earnings Summary — Q4 FY2026

• Revenue grew 24.3% year-on-year to ₹460 crores, demonstrating sustained demand in the niche pediatric segment.
• Net profit saw a significant 36.8% YoY jump, primarily aided by a sharp reduction in effective tax rate to 10% this quarter.
• Operating Profit Margin remained healthy at 31%, although it softened compared to the 33% seen in the preceding two quarters.
• Borrowings increased to ₹891 crores by year-end, reflecting capital-intensive expansion and bed capacity additions.
• The company maintains a strong doctor-partnership model, which continues to drive high clinician retention and specialized care quality.
• Expansion into NCR and other clusters is ongoing, with significant focus on the 'Rainbow' and 'Birthright' brands.
• Cash flow from operations remains robust at ₹420 crores for the full year, supporting aggressive capex plans.

Management remains focused on adding 1,000+ beds over the medium term. They intend to deepen penetration in established Hyderabad and Bengaluru clusters while expanding the hub-and-spoke model into new territories like NCR and other urban centers.

Stable

While margins faced slight quarterly pressure, the strong year-on-year revenue and profit growth, combined with high operational consistency, reinforces the company's position as a high-quality compounder.

The outlook remains healthy with a clear roadmap for capacity expansion and a focus on maintaining high ARPOB and occupancy through specialized pediatric quaternary care.